Menu
Recruiting NCT07167667

Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities

No phase Interventional Carpal Tunnel Syndrome (CTS)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Paraffin Bath, Extracorporeal Shock Wave Therapy.
Who it may be relevant to
Registry conditions: Carpal Tunnel Syndrome (CTS). Basic parameters: 30 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Investigation of the Effects of Two Different Physiotherapy Modalities on Median Nerve Thickness, Electrophysiological Activity, Pain Intensity and Quality of Life in Patients With Carpal Tunnel Syndrome - An Observational Study

Overview

The study plans to include a total of 60 patients diagnosed with carpal tunnel syndrome. Patients will be divided into two groups according to the treatment they receive. One group will receive only paraffin treatment, while the other group will receive only ESWT treatment. ESWT will be applied for a total of 5 sessions. Paraffin will be applied for a total of 10 sessions. As assessment tools; * Measurement of median nerve thickness with ultrasound * Electromyography * Visual Analog Scale * Short Form-36 Evaluations will be made twice by a specialist physician before and after the treatments.

Interventions

  • Other Paraffin Bath
    Patients' hands will be dipped into the paraffin bath 8-10 times.
  • Other Extracorporeal Shock Wave Therapy
    The patients will be treated with a sound wave pulse frequency of 15 Hz, an intensity of 1.5 bar, and a total number of pulses of 2000 for one session.

Primary outcome measures

  • Median Nerve Thickness [Time frame: Baseline]
  • Median Nerve Thickness [Time frame: 5 days later for the first ESWT intervention and 10 days later for the first Paraffin Intervention]
Secondary outcome measures (5)
  • Electromyography [Time frame: Baseline]
  • Visual Analog Scale [Time frame: Baseline]
  • Visual Analog Scale [Time frame: 5 days later for the first ESWT intervention and 10 days later for the first Paraffin Intervention]
  • Short Form-36 [Time frame: Baseline]
  • Short Form-36 [Time frame: 5 days later for the first ESWT intervention and 10 days later for the first Paraffin Intervention]

Eligibility criteria

Inclusion criteria

  • Individuals between the ages of 30-60 who have been diagnosed with CTS by a specialist physician according to international criteria (Those between Stages 1-3),
  • Those who have complaints of numbness, tingling, and pain in the first three fingers and half of the fourth finger,
  • Phalen Test and Tinel sign or Durkan Test being positive
  • Patients who will receive 5 sessions of ESWT application prescribed by a Physical Medicine and Rehabilitation Specialist Physician (for the ESWT group)
  • Patients who have been recommended 10 sessions of Paraffin application by a Physical Medicine and Rehabilitation Specialist Physician (for the Paraffin group)

Exclusion criteria

  • Presence of atrophy in the thenar muscles,
  • Insufficient sensory and motor response in the median nerve,
  • History of hand and/or wrist injury or surgery,
  • Those with cervical stenosis, cervical spondylosis, or cervical radiculopathy,
  • Corticosteroids in the carpal tunnel area within the last six months those who have had an injection,
  • Pregnancy or diabetes, renal failure, rheumatoid arthritis or hypothyroidism

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Baltalimani Metin Sabanci Bone Diseases Training and Research Hospita — Istanbul

Identifiers

NCT: NCT07167667 · 2024/145

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗